The New PBM Blueprint: Inside Rightway's Clinical Strategy with Dave Stackhouse.

In the fourth episode of The New PBM Blueprint, host Joe Chamberlin sits down with Dave Stackhouse, Vice President of PBM Clinical Strategy and Operations at Rightway. Dave got his start in community pharmacy in Western New York and later spent 22 years in managed care.

He explains why Rightway built its clinical strategy around lowest net cost instead of rebate guarantees, and how that decision drove its early, aggressive move into biosimilars once Humira lost exclusivity. Dave also walks through Rightway's partnership with Mark Cuban Cost Plus Drugs, how it pressures specialty pharmacies to compete on price, and the thinking behind a pharmacy navigation team built to put a pharmacist within reach of every family Rightway serves.

Subscribe on Apple Podcasts, Spotify, or wherever you get your podcasts.